 Vojtech Petr
| Title | Post-Doctoral Fellow |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-MED |
|---|
|
|
|
 Bibliographic
-
Petr V, Thurman JM. The role of complement in kidney disease. Nat Rev Nephrol. 2023 12; 19(12):771-787. PMID: 37735215.
-
Zahradka I, Petr V, Jakubov K, Modos I, Hruby F, Viklicky O. Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine. Front Med (Lausanne). 2023; 10:1252822. PMID: 37795416.
-
Eskandari SK, Gaya da Costa M, Faria B, Petr V, Azzi JR, Berger SP, Seelen MAJ, Damman J, Poppelaars F. An interleukin 6-based genetic risk score strengthened with interleukin 10 polymorphisms associated with long-term kidney allograft outcomes. Am J Transplant. 2022 12; 22 Suppl 4:45-57. PMID: 36453708.
-
Petr V, Zahradka I, Modos I, Roder M, Prewett A, Fialova M, Machkova J, Hruba P, Magicova M, Slavcev A, Striz I, Viklicky O. First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft. Transplantation. 2023 02 01; 107(2):e62-e64. PMID: 36314999.
-
Zahradka I, Petr V, Modos I, Kabrtova K, Slavcev A, Viklicky O. SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation. Transplantation. 2022 12 01; 106(12):e522-e524. PMID: 36245078.
-
Petr V, Csuka D, Hruba P, Szil?gyi ?, Kollar M, Slavcev A, Proh?szka Z, Viklicky O. MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy. Front Immunol. 2022; 13:985766. PMID: 36189289.
-
Zahradka I, Petr V, Modos I, Magicova M, Dusek L, Viklicky O. Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report. Ann Intern Med. 2022 07; 175(7):961-968. PMID: 35500256.
-
Zahradka I, Petr V, Magicova M, Viklicky O. Background risk should be taken into account when reporting vaccine effectiveness. Am J Transplant. 2022 07; 22(7):1927-1928. PMID: 35043536.
-
Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O, Abramowicz D, Naik M, Mayer G, Oberbauer R. Waiting Time for Second Kidney Transplantation and Mortality. Clin J Am Soc Nephrol. 2022 01; 17(1):90-97. PMID: 34965955.
-
Petr V, Hruba P, Kollar M, Krejci K, Safranek R, Stepankova S, Dedochova J, Machova J, Zieg J, Slatinska J, Pokorna E, Viklicky O. Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss. Transplant Direct. 2021 Nov; 7(11):e779. PMID: 34712779.
-
Cahova M, Kveton M, Petr V, Funda D, Dankova H, Viklicky O, Hruba P. Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney Blood Press Res. 2021; 46(2):245-249. PMID: 33756485.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2021 | 3 | | 2022 | 6 | | 2023 | 2 |
To return to the timeline, click here.
|
Petr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|